20/20 BIOLABS, INC. (AIDX) Gross margin 2024–2025
20/20 BIOLABS, INC. (AIDX) gross margin by fiscal year — reported gross profit divided by reported revenue.
29.6%FY2025 · since FY2024: 20.6% → 29.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.6% | +9.0 pp |
| FY2024 | 20.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice